- Home
- MPC vs EW Comparison
MPC vs EW Comparison
Compare MPC & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPC
- EW
- Stock Information
- Founded
- MPC 1887
- EW 1958
- Country
- MPC United States
- EW United States
- Employees
- MPC N/A
- EW N/A
- Industry
- MPC Integrated oil Companies
- EW Industrial Specialties
- Sector
- MPC Energy
- EW Health Care
- Exchange
- MPC Nasdaq
- EW Nasdaq
- Market Cap
- MPC 49.4B
- EW 42.5B
- IPO Year
- MPC 2011
- EW 2000
- Fundamental
- Price
- MPC $155.48
- EW $70.20
- Analyst Decision
- MPC Buy
- EW Buy
- Analyst Count
- MPC 14
- EW 21
- Target Price
- MPC $184.77
- EW $77.25
- AVG Volume (30 Days)
- MPC 2.0M
- EW 4.5M
- Earning Date
- MPC 11-05-2024
- EW 10-24-2024
- Dividend Yield
- MPC 2.34%
- EW N/A
- EPS Growth
- MPC N/A
- EW 193.69
- EPS
- MPC 12.73
- EW 6.89
- Revenue
- MPC $142,670,000,000.00
- EW $6,314,900,000.00
- Revenue This Year
- MPC N/A
- EW $0.04
- Revenue Next Year
- MPC N/A
- EW $1.30
- P/E Ratio
- MPC $12.22
- EW $10.19
- Revenue Growth
- MPC N/A
- EW 24.02
- 52 Week Low
- MPC $140.98
- EW $58.93
- 52 Week High
- MPC $221.11
- EW $96.12
- Technical
- Relative Strength Index (RSI)
- MPC 47.40
- EW 55.18
- Support Level
- MPC $153.55
- EW $69.35
- Resistance Level
- MPC $158.99
- EW $72.63
- Average True Range (ATR)
- MPC 3.36
- EW 1.73
- MACD
- MPC 0.06
- EW 0.21
- Stochastic Oscillator
- MPC 23.94
- EW 66.80
About MPC Marathon Petroleum Corporation
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 3.0 million barrels per day. Its Dickinson, North Dakota, facility produces 184 million gallons a year of renewable diesel. Its Martinez, California, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed master limited partnership, MPLX.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.